Hypoxia-inducible factor-1 alpha (HIF-1a) constitutes a regulatory subunit of HIF-1, a major transcriptional activator of genes that coordinate physiological and pathological responses towards hypoxia. In order to identify novel interaction partners of HIF-1a we have applied T7 phage display system and identified a domain inherent in the retinoblastoma protein (pRB). The interaction between pRB and HIF-1a was confirmed by in vitro experiments and in transfected cells. Thereby, an HIF-1a domain spanning amino acids 530-694 was mapped to be required for pRB binding. Overexpression of pRB provoked transcriptional activation of HIF-1a under normoxia. Furthermore, the domain of pRB identified to bind HIF-1a in vitro is sufficient to cause HIF-1a transcriptional activation with the further notion that phosphorylation deficient pRB shows stronger HIF1a transactivation. Using ChIP analysis, we show that HIF-1a responsive elements (HREs) are precipitated using a-pRB antibodies. Additionally, a functional interaction between pRB and HIF-1a is confirmed by showing that HIF-1a reverses the transcription repressor function of pRB.
Hypoxia, that is lack of oxygen, is a common stress factor with important roles in development, physiology and pathophysiology. Cells respond to hypoxia by induction of different protective mechanisms such as (i) stabilization of proteins, that is, hypoxia-inducible factor-1 a (HIF-1a) and concomitant expression of specific gene products; (ii) cell cycle arrest and (iii) shifting to anaerobic glycolysis in order to maintain cellular homeostasis (for reviews see Bunn and Poyton, 1996; Semenza, 2000 Semenza, , 2001 . To date the best studied mechanism that is turned on in hypoxia is stability regulation of HIF-1a (for a review see Chun et al., 2002; Wenger, 2002; Huang and Bunn, 2003) . Together with HIF-1b (ARNT), HIF-1a builds a heterodimer HIF-1, which is a master regulator of oxygen homeostasis. HIF-1 binds to hypoxia responsive elements (HRE) that are present in enhancer or promoter regions of inducible genes, which play essential roles in response to hypoxia, including glycolysis (e.g. glucose transporter-1 (GLU-1)), erythropoiesis (e.g. erythropoietin (EPO)) and angiogenesis (e.g. vascular endothelial growth factor (VEGF)). Whereas HIF-1b is constitutively expressed, HIF-1a accumulation is steeply induced in hypoxia. In normoxic cells, HIF-1a is rapidly ubiquitinated and subjected to proteosomal degradation by the 26S-proteasome. A critical role in the ubiquitination of HIF-1a in the presence of oxygen plays the von HippelLindau (VHL) protein, a putative E3 ubiquitin ligase (for a review see Kondo and Kaelin, 2001) . In some analogy to hypoxia, exposure of cells to cobalt chloride or iron chelators (e.g. desferrioxamine), which mimic hypoxic conditions, induces HIF-1a expression and inhibits HIF-1a ubiquitination by dissociating VHL from HIF-1a.
To date a number of HIF-1a interaction partners has been identified. They include VHL (Cockman et al., 2000) , CBP/p300 (Arany et al., 1996) , SRC-1 (Carrero et al., 2000) , p53 , Jab1 (Bae et al., 2002) , hsp90 (Gradin et al., 1996) , FIH-1 (Mahon et al., 2001) and others. The regulation of HIF-1a activity/ stability includes (i) post-translational modification of HIF-1a protein itself (i.e. hydroxylation) and (ii) interaction with other cellular proteins. For further HIF-1a characterization, identification of novel interaction partners is an aim. Towards this, we have applied T7 phage display (Rodi and Makowski, 1999; Sche et al., 1999) . Phage display utilizes a T7 bacteriophage-based surface display system, which allows fusion of cloned proteins to the C-termini of phage capsid proteins. This feature has facilitated a construction of cDNA libraries that are commercially available (Novagen, Wisconsin, USA). At first, GST-fusion constructs expressing different domains of HIF-1a such as amino acids 1-211, 204-398, 390-571 and 564-826 have been constructed, followed by respective protein expression in bacteria. Expressed GST-tagged HIF-1a fragments were bound to beads and used for multistep screening of an amplified random primed human brain cDNA library (T7Select TM from Novagen, WI, USA).
Nucleotide sequences of isolated phages were determined and analysed for homology using the basic alignment research tool (BLAST). One of the peptides exposed on the recombinant T7 phages isolated in screening with GST-HIF-1a (amino acids 390-571) revealed similarity to a sequence in the C-terminal domain of the retinoblastoma susceptibility gene product pRB ( Figure 1a ). The interaction between the fulllength proteins was confirmed by pull-down experiment. For this, control (GST-APAF
1À412
) and GST-pRB proteins were expressed in bacteria and used to pull down in vitro synthesized HIF-1a by utilizing glutathione sepharose. Experiment presented in Figure 1b shows that HIF-1a is specifically pulled down by GSTpRB. Additionally, we determined whether pRB and HIF-1a associate in cells. Therefore, HEK293 cells were mock transfected (control) or with an expression plasmid encoding HA-tagged HIF-1a and cell lysates were purified on anti-HA agarose. Result presented in Figure 1c shows that pRB is specifically precipitated with HA-HIF-1a (compare lanes 1 and 2). Also, we have examined which domain of HIF-1a is required for pRB/ HIF-1a interaction in cells. To this end, HEK293 cells were co-transfected with plasmids encoding fusions of GST with different HIF-1a domains (described in Cho et al., 2001) together with a pRB expression vector. Cell lysates were purified over glutathione (GSH) sepharose and tested for the presence of pRB. Results presented in Figure 1d demonstrate that HIF-1a and pRB complex in cells. The experiment allowed to map the HIF-1a domain resembling amino acids 530-694 as an interaction surface for pRB. Interestingly, in phage display, HIF-1a 390-571 was used to fish a peptide similar to pRB, whereas data from pull down experiments indicate Comparison and alignment of aminoacid sequences to pRB. Identical amino acids are in bold, plus represent amino acids of the same charge and X points to amino acids that could not be explicitly determined. Handling of T7 phages was performed according to the T7Select TM System Manual provided by the manufacturer (Novagen, Bad Soden, Germany). Pannings were performed with 15-20 mg of GST-HIF-1a (aa 390-571) immobilized to glutathione beads (GSH-sepharose) with 3 Â 10 9 phage particles from random-primed human brain cDNA library (in T7Select 10-3) in buffer containing 1 M KCl, 20 mM TrisHCl (pH 7.9), 5 mM MgCl 2 , 0.2 mM EDTA and 10% glycerol for 1 h at RT with constant agitation. To eliminate enrichment of phage clones interacting with GST, bead or plastic surface, prior to the incubation with the bait, phages were incubated with immobilized GST for 30 min at RT. Unbound phages were then used for panning. After the third or fourth round of panning, phage clones were picked at random and amplified individually. Following standard procedures, DNA was purified, subjected to cycle sequencing and analysed on an ABIPrism 310 sequencer (Big Dye, PerkinElmer, Rodgau-Ju¨gesheim, Germany). GST-HIF-1a (390-571) was constructed by inserting corresponding HIF-1a fragment that was PCR-amplified into pGEX-2TK (Amersham Pharmacia Biotech, Braunschweig, Germany). (b) Binding of 35 Smethionine labeled HIF-1a to GST-pRB. Constructs encoding GST-pRB fusion protein (pGEXKG-hRB 1-928) were obtained from S Mittnacht. As a control GST-APAF-1 1À412 (pGEX4TK2-GST-APAF-1 1À412 , C. Adrain) was used. All GST fusion proteins were expressed in Escherichia coli strain BL21 and purified on glutathione sepharose.
35
S-labeled HIF-1a was generated in TNT reticulocyte lysates (Promega, Mannheim, Germany). For interaction assay, labeled proteins were incubated with GSH-sepharose immobilized GST-fusions (2 mg protein/5 ml beads) for 30 min at RT with constant agitation in buffer containing 250 mM KCl, 20 mM Tris-HCl (pH 7.9), 5 mM MgCl 2 , 0.2 mM EDTA, 10% glycerol and 0.1% NP-40. Beads were washed twice for 15 min at RT with binding buffer and resuspended in Laemmli buffer (50 mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol and 0.1% bromphenol blue). Bead-bound proteins were analysed by SDS-PAGE. (c) HEK293 cells (6 Â 10 6 ) were either mock transfected or received 3 mg of a plasmid encoding HA-HIF-1a. At 4 h before lysis, cells were treated with 100 mM iron chelator 2,2-Diphenyl-1-picrylhydrazil (ICN, Biomedicals Inc. Eschwege, Germany). Cells were lysed in buffer containing 150 mM NaCl, 20 mM Tris-HCl (pH 7.9), 5 mM MgCl 2 , 0.2 mM EDTA, 0.5% NP-40 and lysates were incubated with 10 ml monoclonal anti-HA agarose conjugate (Sigma-Aldrich, Steinheim, Germany) over night at 41C with constant agitation. Beads were washed 3 h with three changes of 500 ml lysis buffer. Proteins bound to beads were resolved on 6% SDS-PAGE gel and visualized by Western analysis using anti-pRB or anti-HIF-1a antibodies (BD Biosciences Pharmingen Heidelberg, Germany) (d) HIF-1a and pRB associate in transfected cells. In total, 2 Â 10 6 HEK293 cells were transfected with 2 mg of plasmids encoding GST-HIF-1a fusions as indicated and 5 mg of the pRB expression plasmid pCDNA3 9E10 encoding wt pRB. For pull-downs of proteins from transfected cells, lysates were incubated over night with GSH-Sepharose in buffer described above but with 150 mM KCl. After washing beads were analysed for the presence of pRB by Western blotting (upper panel) as described (10) using anti-pRB antibodies (BD Biosciences Pharmingen Heidelberg, Germany). In total, 2% of lysates were analysed for the presence of input pRB (middle panel) as well as for GST-HIF-1a fusions using a-GST antibody (Amersham Pharmacia Biotech, Braunschweig, Germany) (bottom panel). Secondary sheep anti-mouse (Amersham) and rabbit anti-goat (Dako, Hamburg, Germany) IgG antibodies were conjugated to horseradish peroxidase. Antigen-antibody complexes were detected by ECL (Amersham) pRB activates hypoxia-inducible factor-1 (HIF-1) A Budde et al that an HIF-1a domain up to amino acid 694 plays a role in pRB binding. Thus, one cannot exclude that other factor(s) are required for efficient pRB/HIF-1a interactions.
The retinoblastoma protein was the first human tumor suppressor to be identified (Bookstein and Lee, 1991) . pRB mutations apart from inherited retinoblastomas have been detected in a wide spectrum of tumors including osteosarcomas, small cell lung carcinomas, breast carcinomas and others (Nevins, 2001) . The most understood role of pRB involves its function in regulating cell cycle-and proliferation-dependent transcription, namely inhibition of E2F transcription factors (Zheng and Lee, 2001 ).
To question functional consequences arising from HIF-1a/pRB interactions we performed transfection assays using the HIF-1a responsive reporter schematically presented in Figure 2a . The reporter contains three HRE elements from the EPO gene fused to a minimal SV40 promoter directing transcription of the luciferase gene (T Kietzmann; Sandau et al., 2001) . In the presence of HIF-1a, expression of the reporter, measured in light units due to the luciferase activity, increased eight-fold (compare column 1 and 2). Co-transfection of increasing amounts of a wild-type pRB expression vector significantly enhanced luciferase activity (columns 3-6), whereas pRB alone did not activate the reporter Recruitment of pRB to native HRE-sites present in EPO and VEGF. Hep3B cells were grown in the presence or absence of 100 mM 2,2-Diphenyl-1-picrylhydrazil (DP) for 18 h as indicated. ChIP analysis was performed according to standard protocols with minor modification (Spencer et al., 2003; Marlowe et al., 2004) . Briefly, cells were grown in 15-cm plates to 80% confluency, treated with DP, crosslinked for 10 min using 1% formaldehyde, washed three times with PBS, resuspended in 750 ml lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.0), homogenized and sonicated to rise DNA pieces between 100 and 800 bp. Cell debris was removed by centrifugation, 1/10 of supernatant was taken as an input, 300 ml RIPA buffer were added to the samples and chromatin was precleared for 20 min at room temperature by incubations with 25 ml of protein A sepharose (Pfizer Deutschland, Kalsruhe, Germany) that was blocked with salmon sperm DNA, BSA and MBS buffer (20 ml casein blocking buffer, 80 ml T-TBS, pH 8.0, 5 g saccarose). The precleared supernatant was incubated overnight on a rotating platform at 41C with 3 mg of either HIF-1a (Affinity Bioreagents, Golden-CO, USA) or pRB (BD Biosciences Pharmingen Heidelberg, Germany) antibodies. DNA pieces bound by the antibodies were precipitated by incubation with 25 ml of protein A sepharose for 15 min at room temperature. Beads were washed with buffer containing 500 mM KCl, 20 mM Tris-HCl (pH 7.9), 5 mM MgCl 2 , 0.2 mM EDTA, 10% glycerol and 0.5% NP-50; RIPA buffer; RIPA/1 M NaCl and TE buffer (1 ml each for 20 min at room temperature). Standard protocols were applied for elution of the immune-complexes, reversal of crosslinks and purification of DNA. Input and ChIP DNA-samples were dissolved in 20 ml ddH 2 O, 3 ml were subjected to PCR amplification with HRE specific primer sets (EPO: (Wang et al., 2004) . PCR products were separated on 1% agarose gels pRB activates hypoxia-inducible factor-1 (HIF-1) A Budde et al construct (columns 7-10). We conclude that pRB enhances transcriptional activation of HIF-1a. Experiments so far had been performed in HEK293, known to constitutively express the adenoviral E1A oncoprotein. In order to exclude that obtained results are cell-type or E1A specific, we performed similar experiments either using another cell line that expresses E1A (E1Awt H4, kindly provided by S Frisch) or E1A-deficient HepG2 cells. Results obtained in E1Awt H4 corroborated data from HEK293 (data not shown). More importantly, confirming results were obtained in E1A-deficient HepG2 cells (Figure 2c) . Thus, overexpression of pRB elicited activation of HIF-1a in HepG2 cells (Figure 2c, columns 3 and 4) . Furthermore, pRB-mediated activation was suppressed when E1A, known to bind to and thus inactivate pRB, was coexpressed (columns 5-7), whereas E1A alone showed no interference (lanes 8 and 9). These results indicate that overexpression of pRB provokes activation of HIF-1a in different cells irrespective of their E1A status.
In order to investigate whether the interaction of pRB and HIF-1a occurs at native HIF-1 responsive elements (HREs), we used chromatin immunoprecipitation (ChIP) analysis. To induce accumulation of HIF-1a, Hep3B cells were treated with an iron chelator (DP). Native chromatin was prepared from cell lysates and precipitated either using antibodies to HIF-1a or pRB. Following ChIP, native HIF-1 binding sites from the EPO and VEGF genes were analysed by PCR (Wang et al., 2004) . As shown in Figure 2d , HIF-1 binding domains present in EPO (the enhancer element in the 3 0 untranslated region approx. 120 bp from the polyadenylation site; from þ 39 to þ 295 from the 3 0 end of the exon 5) and VEGF (5 0 promoter region from -1136 to -889 from the transcription start site) can be precipitated in an HIF-1a, that is, hypoxia-dependent manner (compare lanes 3 and 5). Controls either lacking the antibody (lane 4) or using the anti-HIF-1a antibody with lysate from untreated cells (lane 3) were included to confirm specificity of the precipitation assay. Significantly, antibodies against pRB also immunoprecipitated HRE domains from EPO and VEGF, indicating that pRB is recruited to HRE-sites, most likely via interacting with HIF-1. In agreement with transfection studies we conclude that activation of HIF-1a by pRB involves pRB recruitment to HIF-1 binding sites (HREs).
The growth suppressive function of pRB is regulated by multiple phosphorylation in a cell cycle dependent manner. Specifically, pRB is hypophosphorylated in the G1 phase of the cell cycle and scavenges the transcription factor E2F, required for transcription of genes that promote cell cycle progression. Conditions favoring cell proliferation will phosphorylate pRB in mid-late G1 by cyclin-dependent kinases (CDKs) to liberate E2F, which concomitantly drives transcription of S phase genes (Kaelin, 1999) . To determine whether pRB phosphorylation affects activation of HIF-1a, we compared wt pRB versus pRB in which 15 potential CDK-phosphorylation sites (pRB NPC 1-928) have been mutated in (i) in vitro binding assays and (ii) in transfection assays following HIF-1a-dependent luciferase expression. As shown in Figure 3a (first two panels), both wt and phosphorylation deficient pRB specifically bind to HIF1a (aa 390-571). The phosphorylation deficient pRB mutant showed stronger activation of HIF-1a-dependent transcription of luciferase activity (Figure 3b , compare columns 3 and 4). This is consistent with results in Figure 1b when bacterially expressed and thus underphosphorylated pRB captured HIF-1a. Our results suggest that hypophosphorylated and thus growth suppressive pRB is a potent activator of HIF-1a.
The primary structure of pRB is divided in a number of domains schematically presented in Figure 3a . Two regions termed A and B, which are conserved between other pRB family members such as p107 and p130, constitute a pocket shown to interact with oncoproteins and histone deacetylases. The less conserved C-terminus or C pocket is required, in addition to the A/B pocket, for E2F binding (Kaelin, 1999) . We expressed different fragments of pRB and determined binding to HIF-1a, as well as their ability to activate HIF-1 transcription. No specific interaction of N-terminal (aa 1-300) pRB with HIF-1a (Figure 3a, panel 3 ) was noticed. This is consistent with the lack of HIF-1a dependent luciferase expression (Figure 3b , column 5). pRB (aa 379-928) and particularly pRB (aa 792-928) showed a strong interaction with HIF-1a (Figure 3a) . The identified interaction domain residing in the C-terminus of pRB is in line with our finding from T7 phage display screening. Although the C pocket of pRB (aa 792-928) activates HIF-1a dependent transcription, the effect is three-fold lower compared to wt pRB (Figure 3b, column 8) . These results indicate a correlation between binding and transactivation of HIF-1a and imply that the entire pRB molecule is required for efficient activation of HIF1a. This may suggest the necessity of additional pRB interaction(s) with protein(s) of transcriptional machinery in order to facilitate transcriptional activation of HIF-1a.
We next addressed the question whether pRB/HIF-1a complex formation affects transcription of pRB. Therefore, we used the E2F-dependent luciferase reporter gene construct in HEK293 cells (schematically presented in Figure 4a ) that is repressed when co-transfected with expression plasmids for RB (Figure 4b, column 3) . Significantly, co-expression of HIF-1a partially reverted pRB-mediated repression of E2F-activity (Figure 4b , columns 4-6), while HIF-1a on its own had no effect on E2F-dependent luciferase activity (column 2). As expected, a phosphorylation deficient pRB, presenting hypophosphorylated pRB, more prominently repressed E2F-activity. Under these conditions, co-expression of HIF-1a was even more efficient in regaining E2F-reporter activity (Figure 4b , columns 7-10). Specificity was confirmed when replacing the wt E2F-construct with a mutated one. As seen in Figure 4b (columns 11-15) neither pRB nor HIF-1a affected mutated E2F-reporter activity (p3xmE2Fluc). The results imply that conditions favoring accumulation of HIF-1a will interfere with the repressive function facilitated by pRB. These observations further support the notion of pRB/HIF-1a interactions and pRB activates hypoxia-inducible factor-1 (HIF-1) A Budde et al suggest that the two proteins modulate their functional activity interdependently.
Our intention to identify new interaction partners of HIF-1a succeeded in identifying a domain found in the retinoblastoma protein, when screening HIF-1a with a human brain library presented on T7 bacteriophages. Apart from human, also rat and mouse pRB has been selected by protein sequence comparison (BLAST) (data not shown). This finding initiated further experiments that confirmed the interaction between HIF-1a and retinoblastoma protein, both in vitro and in transfected cells. We went on to demonstrate that HIF-1a/pRB interactions exert functional consequence for the both partners. Whereas, pRB positively influences HIF-1a transactivation, HIF-1a reverses the repressor function of pRB. Future experiments need to define pathophysiological conditions that will be determined by this protein-protein interaction.
It has been shown that overexpression of wt E1A inhibits hypoxic HIF-1-dependent reporter activity (Arany et al., 1996; Sang et al., 2002) . The authors pointed out the relevance of p300/CBP for HIF-1 activation because a mutant form of E1A, incapable of binding to p300/CBP, revealed no inhibition. In contrary, we used two cell lines overexpressing E1A (HEK293 and E1Awt H4) and noticed HIF-1-dependent activation of reporter activity. Taking into account that huge amounts of E1A suffice to completely inhibit p300/CBP, our results may favor the idea that apart from p300/CBP other, possibly pRB-dependent, mechanisms assist in activating HIF-1.
Using a ChIP assay we demonstrate recruitment of pRB to the HRE sites present in genes typically induced by hypoxia such as erythropoietin and VEGF, thus implying direct involvement of pRB in the transcriptional regulation of HIF-1a. However, whether pRB is recruited to HIF-1a before or after its binding to the DNA needs to be addressed in future experiments.
Data presented in Figure 3 suggest that hypophosphorylated and thus active pRB more effectively activates HIF-1. Along this line, it has been reported that hypoxia-induced growth arrest results in accumulation of hypophosphorylated pRB (Ludlow et al., 1993; Amellem et al., 1996; Krtolica and Ludlow, 1996; Danielsen et al., 1998) . Interestingly, accumulation of the growth suppressive form of pRB seems dispensable pRB activates hypoxia-inducible factor-1 (HIF-1) A Budde et al for arresting the cell cycle, as cells lacking pRB stop proliferation under hypoxia as well (Green et al., 2001) . However, it is suggested that rephosphorylation of pRB may control the return to cell cycle progression following reoxygenation. Based on experiment presented in Figure 4b one may propose that accumulation of HIF-1a helps to reverse the growth suppressive function of pRB. Off note, pRB is not required to inhibit E2F-1 since an inactive form of E2F-1 accumulates in hypoxic cells irrespective of their pRB status (O'Conner and Lu, 2000) . Thus, the function of pRB in hypoxia remains unknown. Based on our experiments we propose that the growth suppressive form of pRB contributes to activation of HIF-1a. One may ask under which conditions the amount of pRB increases in a cell. Apart from differentiation and hypoxia when the hypophosphorylated form of pRB, which predominantly affects HIF-1a, accumulates, Hui et al. (1999) reported elevated pRB expression in close association with hepatocellular carcinoma (HCC) progression and metastasis. This implies abnormal pRB expression around the time of progression from a well-to a poorly-differentiated HCCs and in metastatic lesions. The molecular basis for pRB overexpression remained unclear. Based on our observations one may postulate that overexpression/deregulation of pRB in tumor cells will favor activation of HIF-1, which in turn will foster gene expression to promote angiogenesis.
Besides inhibiting E2F-dependent transcription, pRB is also a potent transcriptional activator. Thus, pRB enhances the DNA-binding and transactivation activity of a group of transcription factors involved in cellular differentiation such as C/EBPb (Chen et al., 1996a) , NF-IL6 (Chen et al., 1996b) and MyoD (Gu et al., 1993) . In addition, pRB also activates c-jun which appears to be important for tumor suppression (Nead et al., 1998) . Molecular mechanisms of pRB transcriptional activation are not completely understood. It has been shown that pRB enhances DNA binding activity of C/EBP, but it is not present in the DNA-binding complex, implying a chaperone-like activity of pRB. Along that line, molecular details to explain HIF-1 activation by pRB will require further experimental analysis.
Taken together, our data show a functional interplay between pRB and HIF-1a and propose the relevance of this interaction under diverse patho-physiological conditions. Future investigations will be directed to determine proposed scenarios. , **Point to significant differences compared to either pRB or pRB NPC (t-test, Po0.03) pRB activates hypoxia-inducible factor-1 (HIF-1) A Budde et al
